Results 171 to 180 of about 45,526 (248)

633. Dose-Dependent Gene Silencing by Lentivirus-Mediated RNA Interference (RNAi) in bcr-abl Positive Cells [PDF]

, 2004

openalex   +1 more source

IDENTIFICATION OF E6A2 BCR-ABL FUSION IN A PHILADELPHIA-POSITIVE CML WITH MARKED BASOPHILIA: IMPLICATIONS FOR TREATMENT STRATEGY [PDF]

, 2011
Peter Rohoň, Martina Divoká, Lenka Calabkova, Renata Mojzíková, Beata Katrincsáková, Zuzana Rusinakova, Anna Lapcikova, Luděk Raida, Edgar Faber, Marie Jarošová, Vladimír Divoký, Karel Indrák   +11 more
openalex   +1 more source

Author response for "The landscape of <i>BCR-ABL</i> mutations in patients with Philadelphia chromosome-positive leukaemias in the era of second-generation tyrosine kinase inhibitors"

, 2019
Sheng‐Hsuan Chien, Hsueng-Mei Liu, Po‐Ming Chen, Po‐Shen Ko, Lin Js, Ying‐Ju Chen, Li‐Hsuan Lee, Liang‐Tsai Hsiao, Tzeon‐Jye Chiou, Jyh‐Pyng Gau, Muh‐Hwa Yang, Chunyu Liu   +11 more
openalex   +1 more source

A novel mechanism for imatinib mesylate–induced cell death of BCR-ABL–positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity [PDF]

, 2003
Masayuki Okada, Souichi Adachi, Tsuyoshi Imai, Kenichiro Watanabe, Shinya Toyokuni, Masaki Ueno, Antonis S. Zervos, Guido Kroemer, Tatsutoshi Nakahata   +8 more
openalex   +1 more source

Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia. [PDF]

Oncotarget, 2016
Zhang X, Jia D, Ao J, Liu H, Zang Y, Azam M, Habib SL, Li J, Ruan X, Jia H, Wang X, Li B.   +11 more
europepmc   +1 more source

Next-Generation Sequencing-Based Mutations Scanning Strategy of the BCR-ABL Kinase Domain in Patients with PhiladelPhia-Chromosome Positive Leukemias Treated with Tyrosine Kinase Inhibitors [PDF]

, 2015
De Benedittis
openalex   +1 more source

[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].

, 2019
Yong Liu, R H Mi, Lin-Wanyue Chen, Fangfang Yuan, Qingsong Yin, Yueyue Fu, Xiaotian Zhu, X J Liu, Y L Zhang, W L Zhang, X D Wei   +10 more
openalex   +2 more sources

Expression of the ABL-BCR fusion gene in Philadelphia-positive acute lymphoblastic leukemia [PDF]

, 1993
JV Melo, DE Gordon, Anna Tuszynski, Susheela Dhut, BD Young, JM Goldman   +5 more
openalex   +1 more source

Presence or the Emergence of a F317L BCR-ABL Mutation May Be Associated With Resistance to Dasatinib in Philadelphia Chromosome–Positive Leukemia [PDF]

, 2006
Simona Soverini, Giovanni Martinelli, Sabrina Colarossi, Alessandra Gnani, Fausto Castagnetti, Gianantonio Rosti, Costanza Bosi, Stefania Paolini, Michela Rondoni, Pier Paolo Piccaluga, Francesca Palandri, Panagiota Giannoulia, Giulia Marzocchi, Simona Luatti, Nicoletta Testoni, Ilaria Iacobucci, Daniela Cilloni, Giuseppe Saglio, Michele Baccarani   +18 more
openalex   +1 more source

Advances in Targeting BCR-ABL^T315I Mutation with Imatinib Derivatives and Hybrid Anti-Leukemic Molecules. [PDF]

Molecules
Tuzikiewicz A, Wawrzyniak W, Kutner A, Żołek T.   +3 more
europepmc   +1 more source